Analyze Diet
Veterinary sciences2024; 11(7); doi: 10.3390/vetsci11070299

Putative mRNA Biomarkers for the Eradication of Infection in an Equine Experimental Model of Septic Arthritis.

Abstract: Septic arthritis (SA) in horses has long-term health implications. The success of its resolution hinges on the implementation of early, aggressive treatment, which is often sustained over a prolonged period. Common diagnostic methods do not allow for the reliable detection of the eradication of joint infection. A potential alternative is the discovery and characterization of mRNA biomarkers. The purpose of this study was to identify potential mRNA biomarkers for the eradication of joint infection in equine SA and to compare their expression with our previously published proteomics data. In addition, the transcriptomics data were compared to the mRNA biomarker panel, SeptiCyte Lab, used to distinguish sepsis from non-septic shock in humans. A comparative transcriptomics analysis of synovial fluid from the SA joints of five horses with active infection and subsequent post-treatment eradicated infection in the same joints and five horses with non-septic synovitis was performed. Eight novel mRNA transcripts were identified that were significantly upregulated (>3-fold) in horses with active SA compared to horses post-eradication of infection after treatment and horses with non-septic synovitis. Two proteins in our proteomics data corresponded to these mRNA transcripts, but were not statistically different. The transcripts used in the SeptiCyte test were not differentially expressed in our study. Our results suggest that mRNA may be a useful source of biomarkers for the eradication of joint infection in horses and warrants further investigation.
Publication Date: 2024-07-02 PubMed ID: 39057983PubMed Central: PMC11281635DOI: 10.3390/vetsci11070299Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study investigates potential mRNA biomarkers that could help with detecting when joint infections in horses with septic arthritis have been successfully cleared. Current common diagnostic methods are not reliable for confirming if the infection has been fully eradicated.

Research Objective and Methodology

  • In this study, the researchers were looking for mRNA biomarkers that could reliably indicate the eradication of joint infection in horses with septic arthritis. The earliest and most efficient treatment of septic arthritis (SA), a serious and long-term health issue in horses, greatly enhances the chances of successful resolution. Current diagnostic techniques, however, are not fully reliable in detecting the complete elimination of infection in the joint. The exploration and understanding of mRNA biomarkers offer a potentially more reliable alternative.
  • To carry out this study, a comparative transcriptomics analysis was undertaken. This involved comparing the synovial fluid from the SA joints of five horses with active infection and also post-treatment eradication in the same joints. These samples were also compared to those from five horses suffering from non-septic synovitis. The objective was to identify changes in mRNA levels in active infection, after treatment, and between septic and non-septic conditions.

Findings

  • The study found eight new mRNA transcripts that were significantly upregulated (increased by more than three times) in horses with active SA as compared to those that had completed treatment, and also compared to horses with non-septic synovitis. Two proteins that corresponded to these mRNA transcripts were identified in a previous proteomics study, but they did not show statistically significant differences.
  • The study also compared these findings with the SeptiCyte Lab panel, a set of mRNA biomarkers used to distinguish sepsis from non-septic shock in humans. The researchers found that the transcripts used in the SeptiCyte test were not differently expressed in their study, indicating that the SeptiCyte panel may not be directly applicable for diagnosing infection eradication in horses.

Conclusions and Further Investigation

  • The results suggest that mRNA could serve as a valuable source of biomarkers to affirm the eradication of joint infection in horses. The discovery of these mRNA biomarkers could enable more reliable detection of the clearing of infections after treatment, thereby improving disease management and recovery outcomes.
  • The researchers underline that while their findings are promising, further investigation is needed to confirm the validity of these markers.

Cite This Article

APA
Koziy RV, Bracamonte JL, Katselis GS, Udenze D, Hayat S, Hammond SA, Simko E. (2024). Putative mRNA Biomarkers for the Eradication of Infection in an Equine Experimental Model of Septic Arthritis. Vet Sci, 11(7). https://doi.org/10.3390/vetsci11070299

Publication

ISSN: 2306-7381
NlmUniqueID: 101680127
Country: Switzerland
Language: English
Volume: 11
Issue: 7

Researcher Affiliations

Koziy, Roman V
  • Department of Veterinary Pathology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5B4, Canada.
Bracamonte, José L
  • Department of Large Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5B4, Canada.
Katselis, George S
  • Canadian Centre for Rural and Agricultural Health, Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 2Z4, Canada.
Udenze, Daniel
  • Next-Generation Sequencing Facility, Cancer Research Cluster, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Hayat, Shahina
  • Next-Generation Sequencing Facility, Cancer Research Cluster, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Hammond, S Austin
  • Next-Generation Sequencing Facility, Cancer Research Cluster, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Simko, Elemir
  • Department of Veterinary Pathology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5B4, Canada.

Grant Funding

  • N/A / Townsend Equine Health Research Fund
  • N/A / Mark and Pat DuMont Equine Research Fund

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 28 references
  1. Koziy R.V., Yoshimura S., Dickinson R., Rybicka J.M., Moshynskyy I., Ngeleka M., Bracamonte J.L., Simko E.. Use of Standard Diagnostic Techniques to Determine Eradication of Infection in Experimental Equine Septic Arthritis. Can. J. Vet. Res. 2019;83:24–33.
    pmc: PMC6318826pubmed: 30670899
  2. Schneider R.K., Bramlage L.R., Moore R.M., Mecklenburg L.M., Kohn C.W., Gabel A.A.. A Retrospective Study of 192 Horses Affected with Septic Arthritis/Tenosynovitis. Equine Vet. J. 1992;24:436–442.
  3. Taylor A.H., Mair T.S., Smith L.J., Perkins J.D.. Bacterial Culture of Septic Synovial Structures of Horses: Does a Positive Bacterial Culture Influence Prognosis?. Equine Vet. J. 2010;42:213–218.
    doi: 10.2746/042516409X480403pubmed: 20486977google scholar: lookup
  4. Motta R.G., Martins L.S.A., Motta I.G., Guerra S.T., de Paula C.L., Bolanos C.A.D., da Silva R.C., Ribeiro M.G.. Multidrug Resistant Bacteria Isolated from Septic Arthritis in Horses. Pesqui. Veterinária Bras. Braz. J. Vet. Res. 2017;37:325–330.
  5. Califf R.M.. Biomarker Definitions and Their Applications. Exp. Biol. Med. 2018;243:213–221.
    doi: 10.1177/1535370217750088pmc: PMC5813875pubmed: 29405771google scholar: lookup
  6. . Biomarkers in Equine Synovial Fluid and Serum for the Diagnosis of Joint Diseases. .
    doi: 10.17169/refubium-7852google scholar: lookup
  7. Rifai N., Gillette M.A., Carr S.A.. Protein Biomarker Discovery and Validation: The Long and Uncertain Path to Clinical Utility. Nat. Biotechnol. 2006;24:971–983.
    doi: 10.1038/nbt1235pubmed: 16900146google scholar: lookup
  8. Anderson J.R., Phelan M.M., Foddy L., Clegg P.D., Peffers M.J.. Ex Vivo Equine Cartilage Explant Osteoarthritis Model: A Metabolomics and Proteomics Study. J. Proteome Res. 2020;19:3652–3667.
  9. Yoshimura S., Koziy R.V., Dickinson R., Moshynskyy I., McKenzie J.A., Simko E., Bracamonte J.L.. Use of Serum Amyloid A in Serum and Synovial Fluid to Detect Eradication of Infection in Experimental Septic Arthritis in Horses. Can. J. Vet. Res. 2020;84:198–204.
    pmc: PMC7301682pubmed: 32801454
  10. Koziy R.V., Bracamonte J.L., Yoshimura S., Chumala P., Simko E., Katselis G.S.. Discovery Proteomics for the Detection of Putative Markers for Eradication of Infection in an Experimental Model of Equine Septic Arthritis Using LC-MS/MS. J. Proteomics. 2022;261:104571.
    doi: 10.1016/j.jprot.2022.104571pubmed: 35346876google scholar: lookup
  11. McHugh L., Seldon T.A., Brandon R.A., Kirk J.T., Rapisarda A., Sutherland A.J., Presneill J.J., Venter D.J., Lipman J., Thomas M.R.. A Molecular Host Response Assay to Discriminate between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery andvValidation in Independent Cohorts. PLoS Med. 2015;12:e1001916.
  12. Miller R.R., Lopansri B.K., Burke J.P., Levy M., Opal S., Rothman R.E., D’Alessio F.R., Sidhaye V.K., Aggarwal N.R., Balk R.. Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU. Am. J. Respir. Crit. Care Med. N. Y. 2018;198:903–913.
    doi: 10.1164/rccm.201712-2472OCpmc: PMC6835074pubmed: 29624409google scholar: lookup
  13. Hart S.N., Therneau T.M., Zhang Y., Poland G.A., Kocher J.-P.. Calculating Sample Size Estimates for RNA Sequencing Data. J. Comput. Biol. 2013;20:970–978.
    doi: 10.1089/cmb.2012.0283pmc: PMC3842884pubmed: 23961961google scholar: lookup
  14. Karunarathna R., Popowich S., Wawryk M., Chow-Lockerbie B., Ahmed K.A., Yu C., Liu M., Goonewardene K., Gunawardana T., Kurukulasuriya S.. Increased Incidence of Enterococcal Infection in Nonviable Broiler Chicken Embryos in Western Canadian Hatcheries as Detected by Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry. Avian Dis. 2017;61:472–480.
    doi: 10.1637/11678-052317-Reg.1pubmed: 29337627google scholar: lookup
  15. Chen S., Zhou Y., Chen Y., Gu J.. Fastp: An Ultra-Fast All-in-One FASTQ Preprocessor. Bioinformatics 2018;34:i884–i890.
  16. Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R.. STAR: Ultrafast Universal RNA-Seq Aligner. Bioinformatics 2013;29:15–21.
  17. Liao Y., Smyth G.K., Shi W.. The R Package Rsubread Is Easier, Faster, Cheaper and Better for Alignment and Quantification of RNA Sequencing Reads. Nucleic Acids Res. 2019;47:e47.
    doi: 10.1093/nar/gkz114pmc: PMC6486549pubmed: 30783653google scholar: lookup
  18. Love M.I., Huber W., Anders S.. Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data with DESeq2. Genome Biol. 2014;15:1–21.
    doi: 10.1186/s13059-014-0550-8pmc: PMC4302049pubmed: 25516281google scholar: lookup
  19. Steel C.M.. Equine Synovial Fluid Analysis. Vet. Clin. N. Am. Equine Pract. 2008;24:437–454.
    doi: 10.1016/j.cveq.2008.05.004pubmed: 18652964google scholar: lookup
  20. Mahaffey E.A.. Chapter 10—Synovial Fluid. In: Cowell R.L., Tyler R.D., editors. Diagnostic Cytology and Hematology of the Horse. 2nd ed. Mosby; St. Louis, MO, USA: 2002. pp. 163–170.
  21. Yu J., Zhang J., Shi M., Ding H., Ma L., Zhang H., Liu J.. Maintenance of Glutamine Synthetase Expression Alleviates Endotoxin-Induced Sepsis via Alpha-Ketoglutarate-Mediated Demethylation. FASEB J. 2022;36:e22281.
    doi: 10.1096/fj.202200059Rpubmed: 35344214google scholar: lookup
  22. Bianchi M.G., Chiu M., Taurino G., Bergamaschi E., C뫝a F., Macaluso G.M., Bussolati O.. The TLR4/NFκB-Dependent Inflammatory Response Activated by LPS Is Inhibited in Human Macrophages Pre-Exposed to Amorphous Silica Nanoparticles. Nanomaterials 2022;12:2307.
    doi: 10.3390/nano12132307pmc: PMC9268534pubmed: 35808143google scholar: lookup
  23. Colotta F., Dower S.K., Sims J.E., Mantovani A.. The Type II ‘Decoy’ Receptor: A Novel Regulatory Pathway for Interleukin 1. Immunol. Today. 1994;15:562–566.
    doi: 10.1016/0167-5699(94)90217-8pubmed: 7848516google scholar: lookup
  24. Lang Y., Jiang Y., Gao M., Wang W., Wang N., Wang K., Zhang H., Chen G., Liu K., Liu M.. Interleukin-1 Receptor 2: A New Biomarker for Sepsis Diagnosis and Gram-Negative/Gram-Positive Bacterial Differentiation. Shock 2017;47:119.
    doi: 10.1097/SHK.0000000000000714pubmed: 27984536google scholar: lookup
  25. Smith C.L., Dickinson P., Forster T., Craigon M., Ross A., Khondoker M.R., France R., Ivens A., Lynn D.J., Orme J.. Identification of a Human Neonatal Immune-Metabolic Network Associated with Bacterial Infection. Nat. Commun. 2014;5:4649.
    doi: 10.1038/ncomms5649pmc: PMC4143936pubmed: 25120092google scholar: lookup
  26. Ng S., Strunk T., Lee A.H., Gill E.E., Falsafi R., Woodman T., Hibbert J., Hancock R.E.W., Currie A.. Whole Blood Transcriptional Responses of Very Preterm Infants during Late-Onset Sepsis. PLoS ONE 2020;15:e0233841.
  27. Huang J., Gao X., Li S., Cao Z.. Recruitment of IRAK to the Interleukin 1 Receptor Complex Requires Interleukin 1 Receptor Accessory Protein. Proc. Natl. Acad. Sci. USA 1997;94:12829–12832.
    doi: 10.1073/pnas.94.24.12829pmc: PMC24223pubmed: 9371760google scholar: lookup
  28. Kulohoma B.W., Marriage F., Vasieva O., Mankhambo L., Nguyen K., Molyneux M.E., Molyneux E.M., Day P.J.R., Carrol E.D.. Peripheral Blood RNA Gene Expression in Children with Pneumococcal Meningitis: A Prospective Case–Control Study. BMJ Paediatr. Open. 2017;1:e000092.
    doi: 10.1136/bmjpo-2017-000092pmc: PMC5862186pubmed: 29637127google scholar: lookup